This innovative development marks a significant advancement in ocular health, offering targeted relief for individuals grappling with dry eyes, a pioneering solution in India.
The incorporation of Vitamin D3 into select lubricant eye drop brands by Entod Pharmaceuticals represents a noteworthy stride in addressing dry eye syndrome, a prevalent condition characterized by discomfort, irritation, and potential vision impairment. Factors contributing to dry eyes include environmental conditions, vitamin deficiencies, poor blinking habits, contact lens wear, extensive digital device use, smoking, and certain medical procedures.
Nikkhil K Masurkar, CEO of Entod Pharmaceuticals, highlighted the benefits of adding Vitamin D3 to routine dry eye treatment. This enhancement has been shown to improve ocular surface health parameters, enhance tear stability, regulate tear osmolarity, and facilitate corneal wound healing. Notably, Vitamin D3 enriched lubricating eye drops will be available exclusively through healthcare professional prescriptions.
Research indicates that insufficient levels of Vitamin D3 can have detrimental effects on eye health, potentially leading to conditions like age-related macular degeneration, diabetic retinopathy, and dry eye syndrome. With this innovative product launch, Entod Pharmaceuticals aims to address these concerns and contribute to overall ocular wellness.
